• ALC-0159: Designing the Next mRNA LNP Logic

  2026-09-29

  ALC-0159 is best understood not as a standalone efficacy driver, but as a PEG-conjugated lipid excipient within a system whose surface behavior, endosomal biology, and tolerability must be optimized together. New evidence on membrane-destabilizing zwitterionic lipids provides a useful framework for deciding how established formulation components can support the next generation of mRNA delivery platforms.

• MLN2238 Proteasome β5 Inhibitor Workflow

  2026-09-29

  MLN2238 gives researchers a reversible, highly potent way to separate β5-driven proteasome stress from broader catalytic-site inhibition in cancer and proteostasis models. This workflow connects dose-controlled target engagement with apoptosis, ROS–JNK–CREB signaling, drug-resistance testing, and practical formulation guidance.

• Candida krusei Forms Trigger Distinct BMEC Apoptosis

  2026-09-28

  Miao et al. show that the yeast and hypha phases of Candida krusei both induce apoptosis in bovine mammary epithelial cells, but engage different dominant pathways. The study combines orthogonal cell-death assays with signaling analysis, providing a useful framework for distinguishing morphotype-specific host responses in fungal mastitis.

• Phenytoin Assay Design: Separating Channel and Enzyme Effect

  2026-09-28

  Phenytoin research requires careful separation of neuronal sodium-channel effects from biochemical assay findings. This guide interprets published paraoxonase-1 inhibition data, explains their limits, and outlines practical choices for concentration planning, controls, and compound handling.

• 3-Aminobenzamide (PARP-IN-1): Evidence & Use

  2026-09-27

  3-Aminobenzamide (PARP-IN-1) is a PARP inhibitor reported to have an approximately 50 nM IC50 in CHO cells. Research applications span oxidative-stress and diabetic-nephropathy models, while coronavirus studies provide a separate rationale for investigating PARP biology—not proof that this compound has antiviral activity.

• Charge-Reversed Exosomes for Cartilage mRNA Delivery

  2026-09-26

  Zhang and colleagues engineered cationic, charge-reversed exosomes to move reporter mRNA through the negatively charged cartilage matrix, a barrier that limits conventional delivery. The study reports deeper cartilage penetration and chondrocyte EGFP expression than with native exosomes, while leaving therapeutic efficacy and long-term safety for future testing.

• Mdivi-1 Workflows for Mitochondrial Fission Research

  2026-09-25

  Use Mdivi-1 to test how mitochondrial fission contributes to hypoxia-associated apoptosis, while pairing drug treatment with mitochondrial, cell-death, and microbiome readouts. A practical workflow separates product-recommended starting conditions from study-specific details that must be verified in the full methods.

• Sex Differences in Angiotensin II Hypertension

  2026-09-25

  Xue and colleagues used telemetry in conscious mice to show that chronic angiotensin II produced a substantially larger blood-pressure rise in intact males than females, with gonadectomy shifting the response in opposite directions by sex. Their measurements also connect the pressure phenotype to altered baroreflex control and a larger ganglionic-blockade-sensitive component in males, while leaving the precise hormonal and neural mechanisms unresolved.

• Caspase-3–NDUFS1 Axis in Trichothecene Liver ROS

  2026-09-24

  A non-peer-reviewed preprint proposes that caspase-3 cleavage of the complex I subunit NDUFS1 amplifies mitochondrial ROS after DON and T-2 toxin exposure, while ER-localized ERO1α contributes a second source of oxidative stress. The findings suggest a connected mitochondrial–ER redox response and identify experiments that can test its contribution to liver-cell injury.

• TNF-alpha Recombinant Murine Protein in Death Assays

  2026-09-24

  Learn how TNF-alpha recombinant murine protein can help distinguish receptor-driven cell death from RNA Pol II degradation-dependent apoptosis. This assay-focused guide translates recent mechanistic findings into practical controls, interpretation rules, and product-handling considerations.

• Gastrin I (human): Reliable Assay Workflows

  2026-09-23

  Practical guidance for using Gastrin I (human), SKU B5358, in receptor-focused gastric physiology experiments and interpreting cell-based assay results. Covers peptide handling, vehicle controls, workflow parameters, model limitations, and evidence-based product selection.

• Cytarabine (AraC): Mechanism and Research Use

  2026-09-23

  Cytarabine, also called AraC, is a deoxycytidine-related nucleoside analog DNA synthesis inhibitor. Its activity depends on deoxycytidine kinase activation, DNA incorporation, and inhibition of polymerase-dependent synthesis, making it a useful leukemia chemotherapy agent and apoptosis research tool.

• Human SAN–Cardiac Plexus Assembloids Model Maturation

  2026-09-22

  The reference study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like tissues to model innervation-associated pacemaker maturation. By integrating electrophysiology with human SAN spatial transcriptomics, the work identifies a prosaposin–GPR37 signaling program and establishes a platform for investigating neuro-cardiac control and conduction disease.

• iPSC Cardiomyocytes for Chemical Hazard and Risk

  2026-09-22

  The reference study demonstrates that combining functional phenotypes with whole-transcriptome responses in human iPSC-derived cardiomyocytes can improve chemical hazard prioritization and mechanistic interpretation. Its concentration-response framework shows that transcriptomic and phenotypic points of departure can provide broadly comparable risk-characterization results while answering different biological questions.

• Gramine, CUL3–MTDH, and Ferroptosis in TNBC

  2026-09-21

  A 2026 study identifies gramine as a selective suppressor of triple-negative breast cancer and defines a CUL3–MTDH ubiquitination mechanism that promotes ferroptosis. By combining chemical screening, target-engagement assays, genetic perturbation, rescue experiments, and xenograft models, the work connects a natural indole alkaloid to a potentially actionable ferroptosis pathway.

8093 records 1/540 page Next 12345 下5页 Last page